Nomenclature for factors of the <scp>HLA</scp> system, update March 2018

Marsh, Steven G.E.

doi:10.1111/iji.12375

Cited by 2 publications

(1 citation statement)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The name A*33:146 has been officially assigned by the World Health Organization (WHO) Nomenclature Committee for Factors of the HLA System in March 2018 2 . The confirmatory sequence of A*33:146 (submission number HWS10060245) was submitted to the IPD‐IMGT/HLA Database 1 in September 2020.…”

Section: Figurementioning

confidence: 99%

Detection of the HLA‐A33:146* allele in a Taiwanese individual

Yang

Lin

2020

HLA

View full text Add to dashboard Cite

show abstract

Section: Figurementioning

confidence: 99%

Detection of the HLA‐A33:146* allele in a Taiwanese individual

Yang

Lin

2020

HLA

View full text Add to dashboard Cite

show abstract

Next-Generation Sequencing Based HLA Typing: Deciphering Immunogenetic Aspects of Sarcoidosis

Kishore

Petřek

2018

Front. Genet.

View full text Add to dashboard Cite

Unraveling of the HLA-related immunogenetic basis of several immune disorders is complex due to the extensive HLA polymorphism and strong linkage-disequilibrium between HLA loci. A lack of in phase sequence information, a relative deficiency of high resolution genotyping including non-coding regions and ambiguous haplotype assignment make it difficult to compare findings across association studies and to attribute a causal role to specific HLA alleles/haplotypes in disease susceptibility and modification of disease phenotypes. Earlier, historical antibody and DNA-based methods of HLA typing, primarily of low resolution at antigen/alellic group levels, yielded “indicative” findings which were partially improved by high-resolution DNA-based typing. Only recently, next-generation sequencing (NGS) approaches based on deep-sequencing of the complete HLA genes combined with bioinformatics tools began to provide the access to complete information at an allelic level. Analyzing HLA with NGS approaches, therefore, promises to provide further insight in the etiopathogenesis of several immune disorders in which HLA associations have been implicated. These range from coeliac disease and rheumatological conditions to even more complex disorders, such as type-1 diabetes, systemic lupus erythematosus and sarcoidosis. A systemic disease of unknown etiology, sarcoidosis has previously been associated with numerous HLA variants and also other gene polymorphisms, often in linkage with the HLA region. To date, the biological significance of these associations has only partially been defined. Therefore, more precise assignments of HLA alleles/haplotypes using NGS approaches could help to elucidate the exact role of HLA variation in the multifaceted etiopathogenesis of sarcoidosis, including epigenetic mechanisms. NGS-based HLA analyses may be also relevant for defining variable clinical phenotypes and for predicting the disease course or the response to current/plausible novel therapies.

show abstract

Nomenclature for factors of the HLA system, update March 2018

Cited by 2 publications

References 18 publications

Detection of the HLA‐A33:146* allele in a Taiwanese individual

Detection of the HLA‐A33:146* allele in a Taiwanese individual

Next-Generation Sequencing Based HLA Typing: Deciphering Immunogenetic Aspects of Sarcoidosis

Contact Info

Product

Resources

About

Nomenclature for factors of the HLA system, update March 2018

Cited by 2 publications

References 18 publications

Detection of the HLA‐A*33:146 allele in a Taiwanese individual

Detection of the HLA‐A*33:146 allele in a Taiwanese individual

Next-Generation Sequencing Based HLA Typing: Deciphering Immunogenetic Aspects of Sarcoidosis

Contact Info

Product

Resources

About

Detection of the HLA‐A33:146* allele in a Taiwanese individual

Detection of the HLA‐A33:146* allele in a Taiwanese individual